With Cox-2 inhibitors such as Vioxx and Bextra pulled from the market, people have been looking for replacements.
A Pharmacor study indicates that antidepressants will emerge as the new market leaders in medication for chronic low back pain. Antidepressants treat both the pain and its accompanying depression.

